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Abbreviations {#nc005}
=============

PVL

:   Paravalvular leak

TTE

:   Transthoracic echocardiography

TEE

:   Transoesophageal echocardiography

AVR

:   Aortic valve replacement

MVR

:   Mitral valve replacement

PWD

:   Pulsed wave Doppler

CWD

:   Continuous wave Doppler

EOA

:   Effective orifice area

VTI Pr V

:   Velocity-time integral through the prosthetic heart valve

DVI

:   Doppler velocity index

LDH

:   Lactate dehydrogenase

RHD

:   Rheumatic heart disease

IE

:   Infective endocarditis

Introduction {#s0005}
============

The presence of paravalvular leaks (PVLs) is a well-known complication after both aortic (AVR) and mitral (MVR) valve replacements. It occurs because of the incomplete apposition of the sewing ring to the native annular tissue. PVLs can be seen either immediately after valve replacement in the operating room or during the follow-up period. The immediate PVLs usually are associated with technical difficulties related to calcification of the native annulus. Late PVLs are commonly a consequence of suture dehiscence caused by prosthetic valve endocarditis or the gradual resorption of incompletely debrided annular calcifications [@b0005]. Although most PVLs are asymptomatic and have a benign clinical course, an estimated 1--5% of patients with PVLs can develop serious clinical consequences [@b0010].

Patients with symptomatic PVLs present with congestive heart failure from volume overload in 90% of cases and hemolytic anemia from shear stress on the red blood cells ranging from one-third to three-quarters of cases. Hemolysis can be identified by serum lactate dehydrogenase level \>460 U/L and any two of the following criteria blood hemoglobin \<13.8 g/dL for males or \<12.4 g/dL for females, serum haptoglobin \<50 mg/dL, and reticulocyte count \>2%. Severe hemolytic anemia may even manifest as congestive heart failure [@b0015].

Furthermore, PVL, like any intracardiac defect creating a significant turbulent flow, is an important pre-existing condition in the context of bacteremia to develop infective endocarditis [@b0010].

Transthoracic echocardiography (TTE) along with transoesophageal echocardiography (TEE) can be utilized to determine these spatial characteristics and prosthetic valve function. Three-dimensional TEE is superior to two-dimensional TEE for evaluation of PVL regurgitation because it provides improved localization and analysis of the PVL size and shape, especially in patients with multiple PVLs [@b0020].

Until recently, surgery has been the only available therapy for the treatment of clinically significant PVLs despite the significant mortality associated with reoperation [@b0025], [@b0030]. The transcatheter closure of PVLs is performed using trans-septal, retrograde transaortic, and/or left ventricular (LV) transapical approaches. The choice of approach depends on the valve involved, the location of the leak, the presence of mechanical valves hindering entry, and the vascular access difficulties of an individual patient. There are several complications that can occur either during transcatheter closure or in follow-up. Complications include the need for emergency cardiac surgery in 0.7--2% and death in 1.4--2% [@b0035].

The aim of the current study was not only to evaluate the incidence, causes, and short-term outcome of PVL with variable degree of severity in patients with prosthetic cardiac valves, but also to describe the association of hemolytic anemia with different grades of PVL.

Patients and methods {#s0010}
====================

Study design {#s0015}
------------

This was an observational study in which we collected data from patients with mechanical or biological valve prostheses complicated with PVL presenting to the Cardiovascular Department at Cairo University Hospital, Egypt for aortic and/or mitral valve replacement surgery from May 2014 to May 2015. Patients were subjected to history taking and physical examination. Demographic parameters were recorded, including age, sex, and body mass index. Written informed consent was obtained from all participants. The study protocol was approved by the Ethics Committee at Cairo University Hospital. Patients who were not willing to participate in the study or refused to undergo TEE were excluded.

Laboratory data {#s0020}
---------------

Hemolytic anemia was detected by blood analysis for hemoglobin, bilirubin (total and direct), lactate dehydrogenase, and reticulocyte count. Patients with suspected infective endocarditis (IE) had three sets of blood cultures that were withdrawn in aerobic and anaerobic media from three different venipuncture sites under complete aseptic precautions.

Echocardiography analysis {#s0025}
-------------------------

All patients had TTE before valve replacement and early postoperative before discharge to screen for early PVL. If there was any clinical suspicion of PVL such as symptoms of heart failure, newly developed murmur at auscultation, or laboratory findings of anemia, an additional TTE was performed. If findings were inconclusive, TEE was performed. Echocardiography was performed with all patients in the left lateral decubitus position. Standardized measurement and evaluation of the size of all cardiac chambers, LV wall thickness and function, left atrial size, and estimation of pulmonary artery systolic pressure were done by commercial scanner (iE33 Philips Medical Systems, Andover, MA, USA) according to the recommendations of the American Society of Echocardiography [@b0040].

Statistical analysis {#s0030}
--------------------

Data were summarized using mean, standard deviation, median, minimum and maximum in quantitative data, and using frequency (count) and relative frequency (percentage) for categorical data. Comparisons between quantitative variables were done using the nonparametric Kruskal--Wallis and Mann--Whitney tests. For comparing categorical data, the χ^2^ test was performed. Fisher's exact test was used instead when the expected frequency was \<5. A *p* value \<0.05 was considered statistically significant. Data were coded and entered using SPSS version 22 (Chicago, IL, USA).

Results {#s0035}
=======

The study included 200 patients who underwent mitral and/or aortic valve replacement at Cairo University Hospital, New Kasr Al Ainy Teaching Hospital, and National Heart Institute Cairo, Egypt from May 2014 to May 2015 ([Fig. 1](#f0005){ref-type="fig"}). Patients were divided into Group I with 175 patients with replaced prosthetic heart valve with no PVL, and Group II with 25 patients with early PVL. All patients were subjected to clinical evaluation and echocardiography assessment before and after surgery, before discharge from hospital, and after 3 months follow-up. The mean age of the patients was 38.9 ± 12.3 years ([Table 1](#t0005){ref-type="table"}). The mitral valve, aortic valve, and both valves were replaced in 80, 77, and 43 patients, respectively ([Table 2](#t0010){ref-type="table"}). Rheumatic heart disease (RHD) and IE were the most common underlying pathology for valve replacement ([Fig. 2](#f0010){ref-type="fig"}). Heart failure symptoms were the most common presentation followed by symptoms suggestive of IE.Fig. 1Flow chart for all patients included in the study. PVL = paravalvular leak.Fig. 2Preopertive long axis tranesophageal study showing aortic root abscess. Transesophageal images of a patient with significant aortic regurgitation and aortic root abscess, with an underlying pathology of infective endocarditis. LA = left atrium; LV = left ventricle; LVOT = left ventricle outflow tract.Table 1Baseline clinical evaluation for all patients.VariableAll patients\
(*n* = 200)Patients with postoperative paravalvular leak (*n* = 25)Age (y)38.9 ± 12.334.48 ± 9.39Sex Male108 (54%)16 (64%) Female92 (46%)9 (36%)Underlying valve etiology Rheumatic valve lesion150 (75%)18 (72%) Infective endocarditis33 (16.5%)16(64%) Bicuspid aortic valve16 (8%)3 (12%)Clinical presentation Heart failure194 (97%)24 (96%) Infective endocarditis29 (14.5%)14 (56%) Embolic events25 (12.5%)14 (56%)Table 2Surgical data for all patients and patients with paravalvular leak.VariableAll patients\
(*n* = 200)Paravalvular leak patients (*n* = 25)Valve replaced Mitral80 (40%)3 (12%) Aortic77 (36%)7 (28%) Both43 (21.5%)15 (60%)Type of valve replacedMechanical198 (99%)25 (100%)Bioprosthesis2 (1%)0 (0%)

Laboratory workup revealed that hemoglobin was significantly low in patients with PVL compared with those without PVL (9.8 vs. 11.2 g/dL, *p* = 0.02). Moreover, total bilirubin, LDH, and reticulocyte count were elevated in patients with PVL (*p* = 0.313, *p* = 0.002, and *p* = 0.045, respectively). There was trend in renal impairment defined as elevation of serum creatinine \>1.3 mg/dL (according to reference value in our laboratories) or glomerular filtration rate \<60 mL/min/1.73 m^2^ among patients with PVL compared with patients without PVL (*p* = 0.027).

The incidence of early PVL was higher in patients who had both mitral and aortic valves replaced compared with those with only one valve replaced. Previous valve replacement was significantly higher in patients with PVL compared with those without PVL (*p* \< 0.001) with no significant difference in other valve surgeries (mitral valve repair or comissurotomy) ([Table 3](#t0015){ref-type="table"}).Table 3Patients with and without paravalvular leak according to the type of previous surgery.Group I\
*n* = 175Group II\
*n* = 25*P*Count%Count%Mitral valve replaced\
(previous surgery)Yes169.11768.0\<0.001No15990.9832.0Aortic valve replaced\
(previous surgery)Yes42.32288.0\<0.001No17197.7312.0Mitral commisurotomy\
(previous surgery)Yes52.900.01.000No17097.125100.0Mitral valve repair\
(previous surgery)Yes31.700.01.000No17298.325100.0No174100.02496.0[^1]

IE was significantly high in patients with PVL compared with patients without PVL (*p* \< 0.001). Aortic root abscess was found in 5.6% of patients with IE without PVL (*n* = 1/18) compared with 53.3% of patients with IE and PVL (*n* = 8/15; *p* = 0.004) ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Early postoperative paravalvular leak due to infective endocarditis showing aortic root abscess. Long-axis view of transesophageal echocardiography showing abscess cavity related to prosthetic valve in aortic position, with severe paravalvular leak and central ject of mild mitral regurgitation. AVP = aortic valve prosthesis. LA = left atrium; LV = left ventricle; MR = mitral regurgitation.

Vegetation detected by echocardiography was statistically significant for patients in Group II (*P* value 0.008 and 0.005 for mitral and aortic prosthesis respectively) ([Table 4](#t0020){ref-type="table"}).Table 4Vegetations affecting mitral and aortic prostheses among two study groups.VariablesGroup IGroup II*P*Count%Count%Masses on mitral prosthesisYes10.9317.60.008No10799.11482.4Masses on aortic prosthesisYes00.0313.60.005No100100.01986.4

Echocardiography showed that peak gradients were significantly elevated in patients with PVL compared with those without PVL (*p* \< 0.001 and *p* \< 0.002 for mitral and aortic prosthesis, respectively). Mean gradients were significantly elevated in patients with PVL compared with those without PVL (*p* \< 0.001 and *p* \< 0.015 for mitral and aortic prosthesis, respectively). However, there was no significant difference regarding LV dimensions, left atrial size, aortic root diameters, or LV ejection fraction between patients with and without PVL ([Table 5](#t0025){ref-type="table"}).Table 5Echocardiographic data of the two study groups.VariablesGroup IGroup II*p*MeanSDMeanSDPeak gradient (mitral valve)10.944.0816.064.46\<0.001Mean gradient (mitral valve)4.691.478.243.21\<0.001Peak gradient (aortic valve)25.4812.6037.3218.500.002Mean gradient (aortic valve)14.497.6620.6811.900.015Left ventricular diastolic dimensions5.370.915.330.970.686Left ventricular systolic dimensions3.790.983.721.000.677Aortic root diameter2.860.502.710.540.128Left atrial diameter4.711.064.380.900.277Ejection fraction55.1711.7057.7211.960.279[^2][^3]

Follow-up of patients with postoperative PVL showed well-functioning prostheses in 175 patients with no PVL detected by TTE or TEE ([Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}). Mortality was present in 16% of patients with early prosthetic PVL (*n* = 4/25) due to sepsis. Repeat surgery was done in 11 patients with PVL and was successful in seven patients with no residual leak detected in the early postoperative period and during follow-up. Heart failure symptoms were the most common presentation for patients with residual PVL who did not undergo surgery.Fig. 4Well-functioning mitral valve prosthesis with physiological jet (upper panel) and normal Doppler velocity index (lower panel). LA = left atrium; LV = left ventricle; MR = mitral regurgitation; MVP = mitral valve prosthesis; RA = right atrium; RV = right ventricle; LVOT = left ventricle outflow tract; VTI = velocity time integral; VTI Pr MV = velocity time integral ​through the prosthetic heart valve in mitral position.Fig. 5Well-functioning aortic valve prosthesis with no paravalvular leak LA = left atrium; LV = left ventricle; RV = right ventricle; Aoa = ascending aorta.

The progression of severity in patients with mitral valve PVL varied. Among six patients with mild mitral PVL, one patient died due to associated severe aortic PVL, one patient had no leak on follow-up without intervention; and four patients still had mild PVL. One patient with moderate mitral PVL did not show disease progression and two patients with severe mitral PVL had no leak after surgical repair. As for aortic valve PVL, 19 patients had aortic leak. Three of eight patients with mild leak did not show disease progression, one patient with mild leak died after surgery for aortic root abscess, and one patient with mild aortic leak progressed to severe disease. Patients with mild or moderate PVL not referred for surgery were kept on drugs for heart failure and to reduce afterload.

Discussion {#s0040}
==========

Prosthetic PVL is a serious complication after surgical valve replacement secondary to inappropriate sealing of the prosthetic ring to the native cardiac tissue producing periprosthetic regurgitation. Although most of the cases are mild and asymptomatic regurgitations that are usually detected as an incidental finding, a small percentage of patients show large and clinically significant regurgitations.

The real incidence of PVL is unknown and differs widely between different registries. PVLs are more commonly detected in mechanical valves, especially in the mitral position. Mitral PVL occurs in 7--17% of cases, while aortic PVL occurs in 2--10% of cases [@b0045], [@b0050].

The current study found that the incidence of mitral PVL in the early postoperative period was 3.25%. This is less than what has been reported for early mitral PVL, which varies from 5% to 32% [@b0055]. This can be explained because we only considered patients who had the mitral valve replaced. However, if we calculated the incidence in patients with both valves replaced, the result was 12.2%, which is close to what has been reported. However, the incidence of aortic PVL was 9%. This matches the reported incidence for aortic PVL, which varies from 2% to 17% [@b0060].

The current study found that the incidence of PVL was higher in the aortic prosthesis compared with mitral prosthesis. Previous studies have reported that the overall incidence of PVLs was similar after mitral valve replacement (13%) and aortic valve replacement (11%), and that PVL was more common after bioprostheses insertion in the mitral position and mechanical prostheses in the aortic position. However, they explained that this may be related to mitral annular calcification when compared with the aortic group; technical difficulties during the excision of calcified native mitral valve; and implantation of new bioprostheses were attributed to the higher prevalence of PVLs in this group of patients [@b0065]. One of our study limitations was lack of bioprostheses in our institution.

IE was the most important underlying valve etiology for PVL, which is in accordance with previous studies [@b0070] that found that IE was associated with the highest incidence of PVL. Mullany et al. [@b0075] reported the development of early PVL in IE patients with sustained positive blood culture, despite adequate antibiotic therapy, and advised prolonged antibiotic therapy following diagnosis of PVL and prior to surgery. Moreover, it has been reported that total excision of infected and devitalized tissue should be followed by valve replacement and repair of associated defects to secure valve fixation to avoid leaks in complex cases with locally uncontrolled infection [@b0080], [@b0085].

Although there is widespread agreement among cardiologists and surgeons that severe PVLs should be corrected immediately, there is no consensus regarding the optimal management of patients with mild-to-moderate PVLs. In many of these cases, the risk of untreated PVLs has to be balanced against the consequences of prolonged cardiopulmonary bypass time, which may carry significant incremental risks. Furthermore, there are several reports describing the incidence of perioperative detection of PVLs after valve replacement surgery; however, there is a paucity of data regarding the incidence of PVLs and their association with immediate postoperative outcomes. To the best of our knowledge, no studies have addressed the incidence of early PVL in patients with both mitral and aortic valve replacement. In our study, the incidence was high (35%), compared with patients with one valve replaced.
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[^1]: Results shown are mean ± standard deviation.

[^2]: Results shown as mean ± SD, unless noted otherwise.

[^3]: SD = standard deviation.
